Craneware plc (LON:CRW – Get Free Report) crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of GBX 1,320.89 and traded as low as GBX 1,066. Craneware shares last traded at GBX 1,088, with a volume of 60,557 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank lowered their target price on shares of Craneware from GBX 2,600 to GBX 1,600 and set a “buy” rating on the stock in a research report on Monday, September 21st. Three analysts have rated the stock with a Buy rating. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of GBX 1,673.33.
View Our Latest Research Report on CRW
Craneware Stock Performance
The company has a market capitalization of £381.40 million, a price-to-earnings ratio of 19.89 and a beta of 0.28. The stock’s 50-day moving average price is GBX 1,207.59 and its 200-day moving average price is GBX 1,319.30. The company has a debt-to-equity ratio of 14.60, a quick ratio of 1.00 and a current ratio of 0.83.
Insider Buying and Selling
In other news, insider Susan Nelson bought 1,408 shares of the firm’s stock in a transaction that occurred on Tuesday, September 22nd. The shares were purchased at an average price of GBX 1,054 per share, for a total transaction of £14,840.32. Also, insider Craig Preston sold 14,656 shares of the stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of GBX 1,035, for a total value of £151,689.60. 1.23% of the stock is currently owned by corporate insiders.
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.
Featured Articles
- Five stocks we like better than Craneware
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.
